Literature DB >> 34606370

Pyruvate Oxidase as a Key Determinant of Pneumococcal Viability during Transcytosis across Brain Endothelium.

Anjali Anil1, Shruti Apte1, Jincy Joseph1, Akhila Parthasarathy1, Shilpa Madhavan1, Anirban Banerjee1.   

Abstract

Streptococcus pneumoniae invades a myriad of host tissues following efficient breaching of cellular barriers. However, strategies adopted by pneumococcus for evasion of host intracellular defenses governing successful transcytosis across host cellular barriers remain elusive. In this study, using brain endothelium as a model host barrier, we observed that pneumococcus containing endocytic vacuoles (PCVs), formed following S. pneumoniae internalization into brain microvascular endothelial cells (BMECs), undergo early maturation and acidification, with a major subset acquiring lysosome-like characteristics. Exploration of measures that would preserve pneumococcal viability in the lethal acidic pH of these lysosome-like vacuoles revealed a critical role of the two-component system response regulator, CiaR, which was previously implicated in induction of acid tolerance response. Pyruvate oxidase (SpxB), a key sugar-metabolizing enzyme that catalyzes oxidative decarboxylation of pyruvate to acetyl phosphate, was found to contribute to acid stress tolerance, presumably via acetyl phosphate-mediated phosphorylation and activation of CiaR, independent of its cognate kinase CiaH. Hydrogen peroxide, the by-product of an SpxB-catalyzed reaction, was also found to improve pneumococcal intracellular survival by oxidative inactivation of lysosomal cysteine cathepsins, thus compromising the degradative capacity of the host lysosomes. As expected, a ΔspxB mutant was found to be significantly attenuated in its ability to survive inside the BMEC endocytic vacuoles, reflecting its reduced transcytosis ability. Collectively, our studies establish SpxB as an important virulence determinant facilitating pneumococcal survival inside host cells, ensuring successful trafficking across host cellular barriers. IMPORTANCE Host cellular barriers have innate immune defenses to restrict microbial passage into sterile compartments. Here, by focusing on the blood-brain barrier endothelium, we investigated mechanisms that enable Streptococcus pneumoniae to traverse through host barriers. Pyruvate oxidase, a pneumococcal sugar-metabolizing enzyme, was found to play a crucial role in this via generation of acetyl phosphate and hydrogen peroxide. A two-pronged approach consisting of acetyl phosphate-mediated activation of acid tolerance response and hydrogen peroxide-mediated inactivation of lysosomal enzymes enabled pneumococci to maintain viability inside the degradative vacuoles of the brain endothelium for successful transcytosis across the barrier. Thus, pyruvate oxidase is a key virulence determinant and can potentially serve as a viable candidate for therapeutic interventions for better management of invasive pneumococcal diseases.

Entities:  

Keywords:  Streptococcus pneumoniae; acid tolerance response; blood-brain barrier; endocytic pathway; pyruvate oxidase; two-component system

Mesh:

Substances:

Year:  2021        PMID: 34606370      PMCID: PMC8604078          DOI: 10.1128/JB.00439-21

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  93 in total

1.  Role of oxidative stress in lysosomal membrane permeabilization and apoptosis induced by gentamicin, an aminoglycoside antibiotic.

Authors:  Sophie Denamur; Donatienne Tyteca; Jacqueline Marchand-Brynaert; Françoise Van Bambeke; Paul M Tulkens; Pierre J Courtoy; Marie-Paule Mingeot-Leclercq
Journal:  Free Radic Biol Med       Date:  2011-07-23       Impact factor: 7.376

Review 2.  The many roles of NOX2 NADPH oxidase-derived ROS in immunity.

Authors:  Grace Y Lam; Ju Huang; John H Brumell
Journal:  Semin Immunopathol       Date:  2010-08-28       Impact factor: 9.623

3.  Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils.

Authors:  Ankur B Dalia; Alistair J Standish; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

4.  Identification and structural characterization of a Legionella phosphoinositide phosphatase.

Authors:  Leila Toulabi; Xiaochun Wu; Yanshu Cheng; Yuxin Mao
Journal:  J Biol Chem       Date:  2013-07-10       Impact factor: 5.157

5.  Control of virulence by the two-component system CiaR/H is mediated via HtrA, a major virulence factor of Streptococcus pneumoniae.

Authors:  Yasser Musa Ibrahim; Alison R Kerr; Jackie McCluskey; Tim J Mitchell
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

6.  Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.

Authors:  A Peschel; R W Jack; M Otto; L V Collins; P Staubitz; G Nicholson; H Kalbacher; W F Nieuwenhuizen; G Jung; A Tarkowski; K P van Kessel; J A van Strijp
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

7.  Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Authors:  E N Janoff; J B Rubins; C Fasching; D Charboneau; J T Rahkola; A G Plaut; J N Weiser
Journal:  Mucosal Immunol       Date:  2013-07-03       Impact factor: 7.313

8.  Mucosal Infections and Invasive Potential of Nonencapsulated Streptococcus pneumoniae Are Enhanced by Oligopeptide Binding Proteins AliC and AliD.

Authors:  Jessica L Bradshaw; Haley R Pipkins; Lance E Keller; James K Pendarvis; Larry S McDaniel
Journal:  MBio       Date:  2018-01-16       Impact factor: 7.867

9.  Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.

Authors:  Dilip C Badgujar; Anjali Anil; Angharad E Green; Manalee Vishnu Surve; Shilpa Madhavan; Alison Beckett; Ian A Prior; Barsa K Godsora; Sanket B Patil; Prachi Kadam More; Shruti Guha Sarkar; Andrea Mitchell; Rinti Banerjee; Prashant S Phale; Timothy J Mitchell; Daniel R Neill; Prasenjit Bhaumik; Anirban Banerjee
Journal:  PLoS Pathog       Date:  2020-11-20       Impact factor: 6.823

View more
  1 in total

1.  Development of a Multi-Epitope Vaccine for Mycoplasma hyopneumoniae and Evaluation of Its Immune Responses in Mice and Piglets.

Authors:  Gaojian Li; Jinqi Shu; Jing Jin; Jianhong Shu; Huapeng Feng; Jian Chen; Yulong He
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.